doi: 10.1016/S2213-8587(22)00048-0 Summary Keywords GLP - 1 analog, obesity, treatment, children, adolescents Citation Cominato L, Resende ML, Bernardes N, Rachid LL, Passone CGB, Mattar LBF, Neme G, Souza SG, Santos CRP, Franco RR and Damiani D (2025) 12-month outcomes of GLP - 1 in severe pediatric obesity: real-world data
Proper hydration is recommended to maximize their benefits
TB-4 frag may also help to reduce inflammation
Innovative delivery strategies, including nanotechnology-based formulations, lipid-based nanoparticles, polymeric micelles, and molecular carriers, are being explored to improve EGCGs stability, extend circulation time, and facilitate targeted cellular delivery, overcoming limitations in the compounds structure and metabolic behaviour [96]